Neuroimagen en pacientes con infección por COVID-19 descripción de hallazgos y revisión de la literatura

Lizeth Pardo Hernández; Luisa Fernanda Jaimes Martinez

doi:10.31260/RepertMedCir.01217372.1296

Neuroimaging in patients with COVID-19: findings description and review of the literature

Neuroimagen en pacientes con infección por COVID-19 descripción de hallazgos y revisión de la literatura

Published 2022-04-07

Open | Download

PDF (Spanish) FLIP HTML (Spanish) EPUB (Spanish) text/xml XML (Spanish) audio/mpeg AUDIO (mp3) (Spanish)

Issue

Vol. 31 (2022): Suplemento COVID-19

Section

Review Articles

How to Cite

Pardo Hernández, L., & Jaimes Martinez, L. F. (2022). Neuroimaging in patients with COVID-19: findings description and review of the literature. Journal of Medicine and Surgery Repertoire, 31, 19-27. https://doi.org/10.31260/RepertMedCir.01217372.1296

DOI

https://doi.org/10.31260/RepertMedCir.01217372.1296

Dimensions

PlumX

Citations

Citations in Crossref

Citations in Scopus

Citations in Europe PMC

license

Lizeth Pardo Hernández

Fundación Universitaria de Ciencias de la Salud

Perfil Google Scholar

Luisa Fernanda Jaimes Martinez

Fundación Universitaria de Ciencias de la Salud

Perfil Google Scholar

https://orcid.org/0000-0003-2307-5403

Show authors biography

Luisa Fernanda Jaimes Martinez,

Docente. Instructor Asociado. Fundación Universitaria de Ciencias de la Salud

COVID-19

SARS-CoV-2

neurological manifestations

coronavirus

coronavirus infections

radiology

magnetic resonance imaging

cerebral hemorrhage

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the global spread of coronavirus disease (COVID-19). Our understanding, so far, of the impact this virus has on the nervous system is limited. Our article aims to review the spectrum of neuroimaging findings in patients with COVID 19, as well as, their underlying pathophysiology. Future studies examining the impact of symptoms and their correlation with neuroimaging findings duirng the course of the disease are needed to further clarify and evaluate the association between neurological complications and clinical outcome, as well as to limit long-term consequences.

Article visits 749 | PDF visits 1152

Downloads

Download data is not yet available.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJMoa2001017 DOI: https://doi.org/10.1056/NEJMoa2001017
Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterlé H, et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95(13):e1868-e1882. doi: 10.1212/WNL.0000000000010112 DOI: https://doi.org/10.1212/WNL.0000000000010112
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020;77:8-12. doi: 10.1016/j.jocn.2020.05.017 DOI: https://doi.org/10.1016/j.jocn.2020.05.017
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102-108. doi: 10.1016/j.jpha.2020.03.001 DOI: https://doi.org/10.1016/j.jpha.2020.03.001
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995-998. doi: 10.1021/acschemneuro.0c00122 DOI: https://doi.org/10.1021/acschemneuro.0c00122
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. doi: 10.1002/path.1570 DOI: https://doi.org/10.1002/path.1570
Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, et al. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front Neurol. 2020;11:518. doi: 10.3389/fneur.2020.00518 DOI: https://doi.org/10.3389/fneur.2020.00518
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. doi: 10.1001/jamaneurol.2020.1127 DOI: https://doi.org/10.1001/jamaneurol.2020.1127
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-5. doi: 10.1002/jmv.25728 DOI: https://doi.org/10.1002/jmv.25728
Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25(6):291-4. doi: 10.1016/j.tips.2004.04.001 DOI: https://doi.org/10.1016/j.tips.2004.04.001
Swanson PA, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44-54. doi: 10.1016/j.coviro.2014.12.009 DOI: https://doi.org/10.1016/j.coviro.2014.12.009
Sinha P, Matthay MA, Calfee CS. Is a “Cytokine Storm” Relevant to COVID-19? JAMA Internal Medicine. 2020;180(9):1152-4. doi: 10.1001/jamainternmed.2020.3313 DOI: https://doi.org/10.1001/jamainternmed.2020.3313
Klironomos S, Tzortzakakis A, Kits A, Öhberg C, Kollia E, Ahoromazdae A, et al. Nervous System Involvement in COVID-19: Results from a Retrospective Consecutive Neuroimaging Cohort. Radiology. 2020;297(3):E324-E334. doi: 10.1148/radiol.2020202791 DOI: https://doi.org/10.1148/radiol.2020202791
Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. doi: 10.1016/j.amjoto.2020.102581 DOI: https://doi.org/10.1016/j.amjoto.2020.102581
Heidari F, Karimi E, Firouzifar M, Khamushian P, Ansari R, Mohammadi Ardehali M. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58(3):302-3. doi: 10.4193/Rhin20.140 DOI: https://doi.org/10.4193/Rhin20.140
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-61. doi: 10.1007/s00405-020-05965-1 DOI: https://doi.org/10.1007/s00405-020-05965-1
Strauss SB, Lantos JE, Heier LA, Shatzkes DR, Phillips CD. Olfactory Bulb Signal Abnormality in Patients with COVID-19 Who Present with Neurologic Symptoms. AJNR Am J Neuroradiol. 2020;41(10):1882-7. doi: 10.3174/ajnr.A6751 DOI: https://doi.org/10.3174/ajnr.A6751
Aragão MFVV, Leal MC, Cartaxo Filho OQ, Fonseca TM, Valença MM. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI. AJNR Am J Neuroradiol. 2020;41(9):1703-1706. doi: 10.3174/ajnr.A6675 DOI: https://doi.org/10.3174/ajnr.A6675
Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020;77(8):1028-1029. doi: 10.1001/jamaneurol.2020.2125 DOI: https://doi.org/10.1001/jamaneurol.2020.2125
van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;235(2):277-87. doi: 10.1002/path.4461 DOI: https://doi.org/10.1002/path.4461
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. DOI: https://doi.org/10.1007/s00134-020-06062-x
Garaci F, Di Giuliano F, Picchi E, Da Ros V, Floris R. Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci. 2020;414:116871. doi: 10.1016/j.jns.2020.116871 DOI: https://doi.org/10.1016/j.jns.2020.116871
Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun. 2020;88:940-4. doi: 10.1016/j.bbi.2020.06.005 DOI: https://doi.org/10.1016/j.bbi.2020.06.005
Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. doi: 10.1016/j.nmni.2020.100669 DOI: https://doi.org/10.1016/j.nmni.2020.100669
Morassi M, Bagatto D, Cobelli M, D'Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020;267(8):2185-2192. doi: 10.1007/s00415-020-09885-2 DOI: https://doi.org/10.1007/s00415-020-09885-2
Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282-9. doi: 10.1002/path.1440 DOI: https://doi.org/10.1002/path.1440
Allen LM, Hasso AN, Handwerker J, Farid H. Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics. 2012;32(5):1285-97; discussion 97-9. doi: 10.1148/rg.325115760 DOI: https://doi.org/10.1148/rg.325115760
Meyers PM, Schumacher HC, Higashida RT, Barnwell SL, Creager MA, Gupta R, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2009;119(16):2235-49. doi: 10.1161/CIRCULATIONAHA.109.192217 DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192217
Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: A review. J Med Virol. 2021;93(1):206-222. doi: 10.1002/jmv.26207 DOI: https://doi.org/10.1002/jmv.26207
Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267(10):2799-2802. doi: 10.1007/s00415-020-09951-9 DOI: https://doi.org/10.1007/s00415-020-09951-9